A #Houston#hospital is investigating whether a #doctor altered a #transplant list to make his patients ineligible for care. A disproportionate number of them have died while waiting for new #organs.
A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding.